Skip to main content
. 2021 Nov 21;13(11):1974. doi: 10.3390/pharmaceutics13111974

Table 2.

The affinities between the constructs and HER2 or SAs.

Affibody Carrier HER2 (nM) HSA (nM) MSA (nM)
Z 0.45 ± 0.04 a N.D. b N.D.
Z-ABD 0.41 ± 0.01 0.14 ± 0.03 3.1 ± 0.2
ABD-Z 2.3 ± 0.1 0.95 ± 0.03 6.2 ± 1.2
Z-Z 0.031 ± 0.007 N.D. N.D.
Z-ABD-Z 0.71 ± 0.02 0.62 ± 0.27 3.6 ± 0.3
ABD-Z-Z 0.99 ± 0.07 0.62 ± 0.02 3.3 ± 0.2
Z-Z-ABD 0.84 ± 0.02 0.62 ± 0.03 3.6 ± 0.2

a Each value is the average of three independent measurements ± 1 SD. Representative sensorgrams used for the measurements are shown in Supplementary Figure S1. b Not determined.